Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

It was shown in the present study that several structurally diverse antagonists of the glycine site of the NMDA receptor, including (R)-HA-966, L689,560, 5,7-dichlorokynurenic acid, 7-chlorokynurenic acid, and two of ZENECA's novel pyridazinoindole glycine antagonists, caused marked reversal of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Neural Transmission 1994-01, Vol.97 (3), p.175-185
Hauptverfasser: SLUSHER, B. S, RISSOLO, K. C, JACKSON, P. F, PULLAN, L. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 185
container_issue 3
container_start_page 175
container_title Journal of Neural Transmission
container_volume 97
creator SLUSHER, B. S
RISSOLO, K. C
JACKSON, P. F
PULLAN, L. M
description It was shown in the present study that several structurally diverse antagonists of the glycine site of the NMDA receptor, including (R)-HA-966, L689,560, 5,7-dichlorokynurenic acid, 7-chlorokynurenic acid, and two of ZENECA's novel pyridazinoindole glycine antagonists, caused marked reversal of akinesia when administered intrastriatally to monoamine depleted mice. Coinjection of the glycine agonist D-serine antagonized this locomotor stimulation. In addition, all glycine antagonists tested did not cause significant locomotor stimulation when intrastriatally administered to normal mice. These data suggest that glycine antagonists may offer therapeutic utility in the treatment of idiopathic Parkinson's disease.
doi_str_mv 10.1007/BF02336139
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16766759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16766759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-b6b1fbb9bbd7b29c7f36cdf5b77a2ef8b46714b4d26dfafaa82075239eb5eb603</originalsourceid><addsrcrecordid>eNpFkb1PwzAUxC0EKqWwsCNlQAxIAX8kdjJCRQGpEgsMTJE_nisjxy52OvS_J1WrMj3p7nc33EPomuAHgrF4fF5gyhgnrD1BU1KxuiQVZ6doihnGZVvz6hxd5PyDMSZENBM0EY1ghDZT9D2HMCTp_baUpnfB5QESmGLlt9oFKGQY5Cru5Fy4oBPIDIWPOvZxcDGMWtHHEOUYhdLA2sMwpnun4RKdWekzXB3uDH0tXj7nb-Xy4_V9_rQsNSNkKBVXxCrVKmWEoq0WlnFtbK2EkBRsoyouSKUqQ7mx0krZUCxqylpQNSiO2Qzd7XvXKf5uIA9d77IG72WAuMkd4YJzUbcjeL8HdYo5J7DdOrlepm1HcLfbsfvfcYRvDq0b1YM5oofhRv_24MuspbdJBu3yEasoJfX4gz8WyXw6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16766759</pqid></control><display><type>article</type><title>Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>SLUSHER, B. S ; RISSOLO, K. C ; JACKSON, P. F ; PULLAN, L. M</creator><creatorcontrib>SLUSHER, B. S ; RISSOLO, K. C ; JACKSON, P. F ; PULLAN, L. M</creatorcontrib><description>It was shown in the present study that several structurally diverse antagonists of the glycine site of the NMDA receptor, including (R)-HA-966, L689,560, 5,7-dichlorokynurenic acid, 7-chlorokynurenic acid, and two of ZENECA's novel pyridazinoindole glycine antagonists, caused marked reversal of akinesia when administered intrastriatally to monoamine depleted mice. Coinjection of the glycine agonist D-serine antagonized this locomotor stimulation. In addition, all glycine antagonists tested did not cause significant locomotor stimulation when intrastriatally administered to normal mice. These data suggest that glycine antagonists may offer therapeutic utility in the treatment of idiopathic Parkinson's disease.</description><identifier>ISSN: 0300-9564</identifier><identifier>EISSN: 1435-1463</identifier><identifier>DOI: 10.1007/BF02336139</identifier><identifier>PMID: 7873128</identifier><identifier>CODEN: JNTMAH</identifier><language>eng</language><publisher>Wien: Springer</publisher><subject>Animals ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Behavior, Animal - drug effects ; Biogenic Monoamines - physiology ; Biological and medical sciences ; glycine ; Glycine - antagonists &amp; inhibitors ; Male ; Medical sciences ; Mice ; Motor Activity - drug effects ; Neuropharmacology ; Pharmacology. Drug treatments ; Pyrrolidinones - pharmacology ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors ; Serine - pharmacology ; Stimulation, Chemical</subject><ispartof>Journal of Neural Transmission, 1994-01, Vol.97 (3), p.175-185</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-b6b1fbb9bbd7b29c7f36cdf5b77a2ef8b46714b4d26dfafaa82075239eb5eb603</citedby><cites>FETCH-LOGICAL-c311t-b6b1fbb9bbd7b29c7f36cdf5b77a2ef8b46714b4d26dfafaa82075239eb5eb603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4221546$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7873128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SLUSHER, B. S</creatorcontrib><creatorcontrib>RISSOLO, K. C</creatorcontrib><creatorcontrib>JACKSON, P. F</creatorcontrib><creatorcontrib>PULLAN, L. M</creatorcontrib><title>Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice</title><title>Journal of Neural Transmission</title><addtitle>J Neural Transm Gen Sect</addtitle><description>It was shown in the present study that several structurally diverse antagonists of the glycine site of the NMDA receptor, including (R)-HA-966, L689,560, 5,7-dichlorokynurenic acid, 7-chlorokynurenic acid, and two of ZENECA's novel pyridazinoindole glycine antagonists, caused marked reversal of akinesia when administered intrastriatally to monoamine depleted mice. Coinjection of the glycine agonist D-serine antagonized this locomotor stimulation. In addition, all glycine antagonists tested did not cause significant locomotor stimulation when intrastriatally administered to normal mice. These data suggest that glycine antagonists may offer therapeutic utility in the treatment of idiopathic Parkinson's disease.</description><subject>Animals</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Behavior, Animal - drug effects</subject><subject>Biogenic Monoamines - physiology</subject><subject>Biological and medical sciences</subject><subject>glycine</subject><subject>Glycine - antagonists &amp; inhibitors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Motor Activity - drug effects</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrrolidinones - pharmacology</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><subject>Serine - pharmacology</subject><subject>Stimulation, Chemical</subject><issn>0300-9564</issn><issn>1435-1463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkb1PwzAUxC0EKqWwsCNlQAxIAX8kdjJCRQGpEgsMTJE_nisjxy52OvS_J1WrMj3p7nc33EPomuAHgrF4fF5gyhgnrD1BU1KxuiQVZ6doihnGZVvz6hxd5PyDMSZENBM0EY1ghDZT9D2HMCTp_baUpnfB5QESmGLlt9oFKGQY5Cru5Fy4oBPIDIWPOvZxcDGMWtHHEOUYhdLA2sMwpnun4RKdWekzXB3uDH0tXj7nb-Xy4_V9_rQsNSNkKBVXxCrVKmWEoq0WlnFtbK2EkBRsoyouSKUqQ7mx0krZUCxqylpQNSiO2Qzd7XvXKf5uIA9d77IG72WAuMkd4YJzUbcjeL8HdYo5J7DdOrlepm1HcLfbsfvfcYRvDq0b1YM5oofhRv_24MuspbdJBu3yEasoJfX4gz8WyXw6</recordid><startdate>19940101</startdate><enddate>19940101</enddate><creator>SLUSHER, B. S</creator><creator>RISSOLO, K. C</creator><creator>JACKSON, P. F</creator><creator>PULLAN, L. M</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope></search><sort><creationdate>19940101</creationdate><title>Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice</title><author>SLUSHER, B. S ; RISSOLO, K. C ; JACKSON, P. F ; PULLAN, L. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-b6b1fbb9bbd7b29c7f36cdf5b77a2ef8b46714b4d26dfafaa82075239eb5eb603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Animals</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Behavior, Animal - drug effects</topic><topic>Biogenic Monoamines - physiology</topic><topic>Biological and medical sciences</topic><topic>glycine</topic><topic>Glycine - antagonists &amp; inhibitors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Motor Activity - drug effects</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrrolidinones - pharmacology</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><topic>Serine - pharmacology</topic><topic>Stimulation, Chemical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SLUSHER, B. S</creatorcontrib><creatorcontrib>RISSOLO, K. C</creatorcontrib><creatorcontrib>JACKSON, P. F</creatorcontrib><creatorcontrib>PULLAN, L. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of Neural Transmission</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SLUSHER, B. S</au><au>RISSOLO, K. C</au><au>JACKSON, P. F</au><au>PULLAN, L. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice</atitle><jtitle>Journal of Neural Transmission</jtitle><addtitle>J Neural Transm Gen Sect</addtitle><date>1994-01-01</date><risdate>1994</risdate><volume>97</volume><issue>3</issue><spage>175</spage><epage>185</epage><pages>175-185</pages><issn>0300-9564</issn><eissn>1435-1463</eissn><coden>JNTMAH</coden><abstract>It was shown in the present study that several structurally diverse antagonists of the glycine site of the NMDA receptor, including (R)-HA-966, L689,560, 5,7-dichlorokynurenic acid, 7-chlorokynurenic acid, and two of ZENECA's novel pyridazinoindole glycine antagonists, caused marked reversal of akinesia when administered intrastriatally to monoamine depleted mice. Coinjection of the glycine agonist D-serine antagonized this locomotor stimulation. In addition, all glycine antagonists tested did not cause significant locomotor stimulation when intrastriatally administered to normal mice. These data suggest that glycine antagonists may offer therapeutic utility in the treatment of idiopathic Parkinson's disease.</abstract><cop>Wien</cop><cop>New York, NY</cop><pub>Springer</pub><pmid>7873128</pmid><doi>10.1007/BF02336139</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-9564
ispartof Journal of Neural Transmission, 1994-01, Vol.97 (3), p.175-185
issn 0300-9564
1435-1463
language eng
recordid cdi_proquest_miscellaneous_16766759
source MEDLINE; SpringerNature Journals
subjects Animals
Anticonvulsants. Antiepileptics. Antiparkinson agents
Behavior, Animal - drug effects
Biogenic Monoamines - physiology
Biological and medical sciences
glycine
Glycine - antagonists & inhibitors
Male
Medical sciences
Mice
Motor Activity - drug effects
Neuropharmacology
Pharmacology. Drug treatments
Pyrrolidinones - pharmacology
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Serine - pharmacology
Stimulation, Chemical
title Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T03%3A48%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Centrally-administered%20glycine%20antagonists%20increase%20locomotion%20in%20monoamine-depleted%20mice&rft.jtitle=Journal%20of%20Neural%20Transmission&rft.au=SLUSHER,%20B.%20S&rft.date=1994-01-01&rft.volume=97&rft.issue=3&rft.spage=175&rft.epage=185&rft.pages=175-185&rft.issn=0300-9564&rft.eissn=1435-1463&rft.coden=JNTMAH&rft_id=info:doi/10.1007/BF02336139&rft_dat=%3Cproquest_cross%3E16766759%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16766759&rft_id=info:pmid/7873128&rfr_iscdi=true